It was agreed that Samsonite is to acquire luggage-manufacturer rival Tumi for about $1.8 billion. Samsonite has long been interested in Tumi and its acquisition is considered the biggest deal made by Samsonite.
Goldman Sachs & Co.
- Apple's Vision Pro Production Slashed as Demand Falls Short: Report
- TikTok Voluntarily Suspends New App's Task and Reward Program After EU Regulators Express Concern Over Addictive Effects Among Young Users
- FairPrice Group Launches Mega $4.5 Million Savings Event for May Day: Exclusive Discounts, Deals, and More
Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.
The Rubicon Project Inc. has announced pricing its initial public offering valued at USD15 per share of common stock listed on the New York Stock Exchange.
China Cinda Asset Management Co. Ltd. is looking to raise USD2.45 billion in an initial public offering at the Hong Kong Stock Exchange. Cinda will sell 5.3 billion shares priced at HKD3.00 to HKD3.58 per share.
China's iKang Goubin Healthcare is looking to launch an initial public offering, possibly in NASDAQ, next year. Before the proposed exit, iKang secured a USD100 million joint investment by Goldman Sachs & Co. and sovereign wealth fund Government of Singapore Investment Corporation.
Germany's Metro AG was reportedly considering to float its 25% stake in Cash & Carry Russia by the end of the first quarter or start of the second quarter of 2014. The initial public offering would take place in London and Moscow.
Johnson Controls Inc. on Wednesday announced that it would increase its share repurchase program by USD3 billion. The company also said that it would increase its quarterly dividend to USD22 per common share.
J. Michael Evans, Vice President for Goldman Sachs for emerging markets, is set to retire by this December.
Today, OCI Resources announced that it had launched its initial public offering of 5,000,000 common units.
Cancer metabolism specialist Agios Pharmaceuticals closes its initial public offering on Monday.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- IBM Set to Acquire HashiCorp in Possible Mega-Deal, Stock Skyrockets 24% to $6.1 Billion Valuation
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- Stellantis Plans to Lay Off Unspecified Number of Workers at US Factories in Coming Months